Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 2Multiple Myeloma 2Recurrence 1Platinum-resistant Ovarian Cancer 1Ovarian Cancer Recurrent 1Lymphoma 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Advanced Malignancies 1Adenoviridae Infections 1

Interventions

pembrolizumab 1liposomal doxorubicin 1Everolimus 1Capecitabine 1AZD7648 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Advanced Malignancies × 1-dodecylpyridoxal × Clear all
NCT03907969 2024-02-06

A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.

AstraZeneca

Phase 1/2 Completed
30 enrolled 17 charts

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡